Aroda VR, Frias JP, Ji L, Niemoeller E, et al. Efficacy and Safety of Once-Weekly Efpeglenatide in People with Suboptimally Controlled Type 2 Diabetes: The AMPLITUDE-D, AMPLITUDE-L and AMPLITUDE-S Randomised Controlled Trials. Diabetes Obes Metab 2023 Apr 4. doi: 10.1111/dom.15079.
PMID: 37013892